ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00650832
Brief Title: TMC114-C213: A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV.

First Submitted : March 28, 2008
First Submitted that Met QC Criteria : March 28, 2008
First Posted : April 2, 2008 (Estimate)

Certification/Extension First Submitted : June 2, 2011
Certification/Extension First Submitted that Met QC Criteria : June 2, 2011
Certification/Extension First Posted : June 15, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : June 2, 2011
Last Update Posted : June 15, 2011 (Estimate)